The Under appreciated Role of Lifestyle and Nutrition in Cancer Prevention, Genesis, and Treatment
DOI:
https://doi.org/10.30683/1929-2279.2018.07.04.3Keywords:
Prostate cancer, nano-particles, phytometabolites, solar UVR, cancer stem cells, mastectomy, prevention, diet.Abstract
This article presents a review of the impact of nutrition and lifestyle on the most frequently occurring cancers, including blood, bone, brain, breast, gastric, lung, oral, pancreatic and skin cancers. Heart disease and cancer are the leading causes of morbidity and mortality and the first and second leading causes of death in the United States. Risk of death declined more steeply for heart disease than cancer, offsetting the increase in heart disease deaths, which partially offsets the increase in cancer deaths resulting from demographic changes over the past four decades. Lung cancer is by far the most common cause of cancer-related mortality worldwide in many countries. The incidence rates of lung, colorectal and prostate cancers will continue to rise in the future decades due to the rise of ageing population. Pancreatic cancer is an aggressive malignancy with a poor long-term survival and there has been only slight improvement in outcomes over the past 30 years. Some of the most common contributing factors to various cancers include: genetics, tobacco use, infections, obesity, poor diet, physical inactivity, environmental pollution and hazards, ionizing and ultra-violet radiation (UVR), sunlight, cancer causing substances, chronic inflammation and immunosuppression. This article summarizes recent and tangible cancer control measures which include early detection, weight control, Mediterranean type diet, phytochemicals such as flavonoids, regular physical activity, therapeutic agents, chemotherapy, nano-medicine, medicinal plants and education through mass media awareness.
References
Barone I, Giordano C, Bonofiglio D, Andò S, Catalano S. Phosphodiesterase type 5 and cancers: Progress and challenges. Oncotarget 2017; 8(58): 99179-202. DOI: https://doi.org/10.18632/oncotarget.21837
Strauss M. Earliest Human Cancer Found in 1.7-Million-Year-Old Bone. National Geographic 2016
Odes EJ, Randolph-Quinney PS, Steyn M, Throckmorton Z, Smilg JS, Zipfel B. et al, Earliest hominin cancer: 1.7-million-year-old osteosarcoma from Swartkrans Cave, South Africa. South Afr J Sci 2016; 112(7/8): doi: 10.17159/sajs.2016/ 20150471 DOI: https://doi.org/10.17159/sajs.2016/20150471
Wei Y, Pu X, Zhao L. Preclinical studies for the combination of paclitaxel and curcumin in cancer therapy (Review). Oncol Rep 2017; 37(6): 3159-66. DOI: https://doi.org/10.3892/or.2017.5593
Ramirez CN, Li W, Zhang C, Wu R, Su S, Wang C, et al. In vitro-In vivo Dose Response of Ursolic Acid, Sulforaphane, PEITC, and Curcumin in Cancer Prevention. AAPS J 2018; 20(19). doi: 10.1208/s12248-017-0177-2 DOI: https://doi.org/10.1208/s12248-018-0190-0
Schwingshackl L, Schwedhelm C, Galbete C, Hoffmann G. Adherence to Mediterranean diet and risk of cancer: An updated systematic review and meta-analysis. Nutrients 2017; 9(1063). doi: 10.3390/nu9101063 DOI: https://doi.org/10.3390/nu9101063
Sodrul IMD, Wang C, Chen X, Du J, Sun H. Role of ginsenosides in reactive oxygen species-mediated anticancer therapy. Oncotarget 2018; 9(2): 2931-50. DOI: https://doi.org/10.18632/oncotarget.23407
Siegel RL, Miller KD. Cancer Statistics. CA Cancer J Clin 2017; 67(1):7-30. DOI: https://doi.org/10.3322/caac.21387
Oceans Ltd. Seaweed off N.L. inhibits growth of breast cancer cells: Ocean Tech Company 2018.
Weir HK, Anderson RN, Coleman King SM, Soman A, Thompson TD, Hong Y, et al. Heart Disease and Cancer Deaths - Trends and Projections in the United States, 1969–2020 CME Activity. Prev Chronic Dis 2016; 13(7)160211. doi: http://dx.doi.org/10.5888/pcd13.160211 DOI: https://doi.org/10.5888/pcd13.160211
Misso G, Zarone MR, Grimaldi A, Di Martino MT, Lombardi A, Kawasaki H, et al. Non coding RNAs: A new avenue for the self-tailoring of blood cancer treatment. Curr Drug Targets 2017; 18(1): 35-55. DOI: https://doi.org/10.2174/1389450117666160606104208
Abel GA, Klepin HD. Frailty and the management of hematologic malignancies. Blood 2018; 131(5): 515-24. DOI: https://doi.org/10.1182/blood-2017-09-746420
Schito L, Rey S, Konopleva M. Integration of hypoxic HIF-α signaling in blood cancers. Oncogene 2017; 36(38): 5331-40. DOI: https://doi.org/10.1038/onc.2017.119
Chavez-Gonzalez A, Bakhshinejad B, Pakravan K, Guzman ML, Babashah S. Novel strategies for targeting leukemia stem cells: sounding the death knell for blood cancer. Cell Oncol 2017; 40(1):1-20. DOI: https://doi.org/10.1007/s13402-016-0297-1
Chen Y, Pan Y, Guo Y, Zhao W, Ho WT, Wang J, et al. Tyrosine kinase inhibitors targeting FLT3 in the treatment of acute myeloid leukemia. Stem Cell Investig 2017; 4(6). doi: 10.21037/sci.2017.05.04. DOI: https://doi.org/10.21037/sci.2017.05.04
Chu MP, Kriangkum J, Venner CP, Sandhu I, Hewitt J, Belch AR, et al. Addressing heterogeneity of individual blood cancers: the need for single cell analysis. Cell Biol Toxicol 2017; 33(2): 83-97. DOI: https://doi.org/10.1007/s10565-016-9367-4
Cuesta-Mateos C, Alcaraz-Serna A, Somovilla-Crespo B, Muñoz-Calleja C. Monoclonal antibody therapies for hematological malignancies: Not just lineage-specific targets. Front Immunol 2018; 8(JAN). doi: 10.3389/fimmu.2017.01936 DOI: https://doi.org/10.3389/fimmu.2017.01936
Dempke WCM, Fenchel K, Uciechowski P, Chevassut T. Targeting developmental pathways: The achilles heel of cancer? Oncol 2017; 93(4): 213-23. DOI: https://doi.org/10.1159/000478703
Fruman DA, Chiu H, Hopkins BD, Bagrodia S, Cantley LC, Abraham RT. The PI3K Pathway in Human Disease. Cell 2017; 170(4): 605-35. DOI: https://doi.org/10.1016/j.cell.2017.07.029
McDonald MM, Fairfield H, Falank C, Reagan MR. Adipose, Bone, and Myeloma: Contributions from the Microenvironment. Calcif Tissue Int 2017; 100(5): 433-48. DOI: https://doi.org/10.1007/s00223-016-0162-2
Moloudizargari M, Esmaeil Mortaz MHA, Adcock IM, Frank A, Redegeld JG. Effects of the polyunsaturated fatty acids, EPA and DHA, on hematological malignancies: A systematic review. Oncotarget 2018; 9(14): 11858-75. doi: 10.18632/oncotarget.24405 DOI: https://doi.org/10.18632/oncotarget.24405
Pianko MJ, Liu Y, Bagchi S, Lesokhin AM. Immune checkpoint blockade for hematologic malignancies: A review. Stem Cell Investig 2017; 4(32). doi: 10.21037/sci.2017.03.04 17 DOI: https://doi.org/10.21037/sci.2017.03.04
Wang RF, Wang HY. Immune targets and neoantigens for cancer immunotherapy and precision medicine. Cell Res 2017; 27(1): 11-37. DOI: https://doi.org/10.1038/cr.2016.155
Chen D, Liu D, Chen Z. Potential therapeutic implications of miRNAs in osteosarcoma chemotherapy. Tumor Biol 2017; 39(9). doi: 10.1177/1010428317705762 DOI: https://doi.org/10.1177/1010428317705762
Hutanu D, Popescu R, Stefanescu H, Pirtea, L, Candea A, Sarau, C, et al. The Molecular Genetic Expression as a Novel Biomark in the Evaluation and Monitoring of Patients with Osteosarcoma-Subtype Bone Cancer Disease. Biochem Genet 2017; 55(4): 291-9. DOI: https://doi.org/10.1007/s10528-017-9801-1
Angulo P, Kaushik G, Subramaniam D, Dandawate P, Neville K, Chastain K, et al. Natural compounds targeting major cell signaling pathways: A novel paradigm for osteosarcoma therapy. J Hematol Oncol 2017; 10(1). doi: 10.1186/s13045-016-0373-z DOI: https://doi.org/10.1186/s13045-016-0373-z
Freeman AK, Sumathi VP, Jeys L. Metastatic tumours of bone. Surgery 2018; 36(1): 35-40. DOI: https://doi.org/10.1016/j.mpsur.2017.10.002
Marino S, Idris AI. Emerging therapeutic targets in cancer induced bone disease: A focus on the peripheral type 2 cannabinoid receptor. Pharmacol Res 2017; 119: 391-403. DOI: https://doi.org/10.1016/j.phrs.2017.02.023
Antonuzzo L, Lunghi A, Petreni P, Brugia M, Laffi A, Giommoni E, et al. Osteonecrosis of the jaw and angiogenesis inhibitors: A revival of a rare but serous side effect. Curr Med Chem 2017; 24(28): 3068-76. DOI: https://doi.org/10.2174/0929867324666170511113811
Yang P, Lin J, Liu H, Shen H, Yang HL. Primary bone mantle cell lymphomas with multiple vertebral compression fractures: A case report. Oncol Lett 2017; 13(3): 1288-92. DOI: https://doi.org/10.3892/ol.2017.5553
Regan JN, Trivedi T, Guise TA, Waning DL. The Role of TGFβ in Bone-Muscle Crosstalk. Curr Osteoporosis Rep 2017; 15(1): 18-23. DOI: https://doi.org/10.1007/s11914-017-0344-5
Cheng H, Chawla A, Yang Y, Li Y, Zhang J, Jang HL, et al. Development of nanomaterials for bone-targeted drug delivery. Drug Discov Today 2017; 22(9): 1336-50. DOI: https://doi.org/10.1016/j.drudis.2017.04.021
Kelly M, McNeel D, Fisch P, Malkovsky M. Immunological considerations underlying heat shock protein-mediated cancer vaccine strategies. Immunol Lett 2018; 193: 1-10. DOI: https://doi.org/10.1016/j.imlet.2017.11.001
Reiter RJ, Rosales-Corral SA, Tan DX, Acuna-Castroviejo D, Qin, L, Yang SF, et al. Melatonin, a full service anti-cancer agent: Inhibition of initiation, progression and metastasis. Intern J Mol Sci 2017; 18(4). doi: 10.3390/ijms18040843 DOI: https://doi.org/10.3390/ijms18040843
Bhatt A, Gurnany E, Modi A, Gulbake A, Jain A. Theranostic potential of targeted nanoparticles for brain cancer. Mini-Rev Med Chem 2017; 17(18): 1758-77. DOI: https://doi.org/10.2174/1389557517666170927112150
Ahmadi-Beni R, Khoshnevisan A. An overview of crucial genes involved in stemness of glioblastoma multiforme. Neurochem J 2017; 11(4): 259-65. DOI: https://doi.org/10.1134/S181971241704002X
Huang J, Liu F, Liu Z, Tang H, Wu H, Gong Q, et al. Immune checkpoint in glioblastoma: Promising and challenging. Front Pharmacol 2017; 8:242. doi: 10.3389/fphar.2017.00242 DOI: https://doi.org/10.3389/fphar.2017.00242
Kwatra MM. A rational approach to target the epidermal growth factor receptor in glioblastoma. Curr Cancer Drug Targets 2017; 17(3): 290-96. DOI: https://doi.org/10.2174/1568009616666161227091522
Wali AR, Rennert RC, Wang SG, Chen CC. Prophylactic anticonvulsants in patients with primary glioblastoma. J Neuro-Oncol 2017; 135(2): 229-35. DOI: https://doi.org/10.1007/s11060-017-2584-8
Diksin M, Smith SJ, Rahman R. The molecular and phenotypic basis of the glioma invasive perivascular niche. Int J Mol Sci 2017; 18(11). 2342. doi: 10.3390/ijms18112342 DOI: https://doi.org/10.3390/ijms18112342
Gagné M, Boulay LK, Topisirovic I, Huot MÉ, Mallette FA. Oncogenic Activities of IDH1/2 Mutations: From Epigenetics to Cellular Signaling. Trends Cell Biol 2017; 27(10): 738-52. DOI: https://doi.org/10.1016/j.tcb.2017.06.002
Calabrese G, Daou A, Barbu E, Tsibouklis J. Towards carborane-functionalised structures for the treatment of brain cancer. Drug Discov Today 2018; 23(1): 63-75. DOI: https://doi.org/10.1016/j.drudis.2017.08.009
Lian W, Wang R, Xing B, Yao Y. Fish intake and the risk of brain tumor: A meta-analysis with systematic review. Nutr J 2017; 16(1). doi: 10.1186/s12937-016-0223-4 DOI: https://doi.org/10.1186/s12937-016-0223-4
Matsos A, Loomes M, Zhou I, Macmillan, E, Sabel I, Rotziokos E, et al. Chemotherapy-induced cognitive impairments: White matter pathologies. Cancer Treat Rev 2017; 61: 6-14. DOI: https://doi.org/10.1016/j.ctrv.2017.09.010
Mazur J, Roy K, Kanwar JR. Recent advances in nanomedicine and surviving targeting in brain cancers. Nanomedicine 2018; 13(1): 105-37. DOI: https://doi.org/10.2217/nnm-2017-0286
Razpotnik R, Novak N, Curin Šerbec V, Rajcevic U. Targeting malignant brain tumors with antibodies. Front Immunol 2017; 8(SEP). 1181. doi: 10.3389/fimmu.2017.01181 DOI: https://doi.org/10.3389/fimmu.2017.01181
Sinnaeve J, Mobley BC, Ihrie RA. Space Invaders: Brain Tumor Exploitation of the Stem Cell Niche. Am J Pathol 2018; 188(1): 29-38. DOI: https://doi.org/10.1016/j.ajpath.2017.08.029
Ge YX, Wang CH, Hu FY, Pan LX, Min J, Niu KY, et al. New advances of TMEM88 in cancer initiation and progression, with special emphasis on Wnt signaling pathway. J Cell Physiol 2018; 233(1): 79-87. doi:10.1002/jcp.25853.Epub2017 AR 27 DOI: https://doi.org/10.1002/jcp.25853
Christopoulos PF, Corthay A, Koutsilieris M. Aiming for the Insulin-like Growth Factor-1 system in breast cancer therapeutics. Cancer Treat Rev 2018; 63: 79-95. DOI: https://doi.org/10.1016/j.ctrv.2017.11.010
Choi J, Gyamfi J, Jang H, Koo JS. The role of tumor-associated macrophage in breast cancer biology. Histol Histopathol 2018; 33(2): 133-45.
Roli L, Pecoraro V, Trenti T. Can NGAL be employed as prognostic and diagnostic biomarker in human cancers? A systematic review of current evidence. Int J Biol Mark 2017; 32(1): e53-e61. doi:10.5301/jbm.500045 DOI: https://doi.org/10.5301/jbm.5000245
Adak T, Samadi A, Ünal AZ, Sabuncuoğlu S. A reappraisal on metformin. Regulatory Toxicol Pharmacol 2018; 92: 324-32. DOI: https://doi.org/10.1016/j.yrtph.2017.12.023
Al-Jawadi A, Moussa H, Ramalingam L, Dharamawardhane S, Gollahon L, Gunaratne P, et al. Protective properties of n-3 fatty acids and implications in obesity-associated breast cancer. J Nutr Biochem 2018; 53: 1-8. DOI: https://doi.org/10.1016/j.jnutbio.2017.09.018
de Groot AF, Appelman-Dijkstra NM, van der Burg SH, Kroep JR. The anti-tumor effect of RANKL inhibition in malignant solid tumors – A systematic review. Cancer Treat Rev 2018; 62: 18-28. DOI: https://doi.org/10.1016/j.ctrv.2017.10.010
Colditz GA, Lindsay L. Obesity and cancer: Evidence, impact, and future directions. Clin Chem 2018; 64(1): 154-62. DOI: https://doi.org/10.1373/clinchem.2017.277376
Dalasanur NL, Adhikari R, Singhal J, Chikara S, Awasthi S, Horne D, et al. Translational opportunities for broad-spectrum natural phytochemicals and targeted agent combinations in breast cancer. Int J Cancer 2018; 142(4): 658-70. DOI: https://doi.org/10.1002/ijc.31085
El Hage Chehade H, Wazir U, Mokbel K, Kasem A, Mokbel K. Do online prognostication tools represent a valid alternative to genomic profiling in the context of adjuvant treatment of early breast cancer? A systematic review of the literature. Am J Surg 2018; 215(1): 171-78. DOI: https://doi.org/10.1016/j.amjsurg.2017.05.006
Gallagher K, Marulanda K, Gray S. Surgical Intervention for Lymphedema. Surg Oncol Clin North Am 2018; 27(1): 195-215. DOI: https://doi.org/10.1016/j.soc.2017.08.001
Kenny R, Reed M, Subramanian A. Mastectomy for risk reduction or symmetry in women without high risk gene mutation: A review. Int J Surg 2018; 50: 60-4. DOI: https://doi.org/10.1016/j.ijsu.2017.12.022
Ohri N, Haffty BG. Alternatives to Standard Fractionation Radiation Therapy After Lumpectomy: Hypofractionated Whole-Breast Irradiation and Accelerated Partial-Breast Irradiation. Surg Onco Clin North Am 2018; 27(1): 181-94. DOI: https://doi.org/10.1016/j.soc.2017.07.006
Raphael J, Desautels D, Pritchard KI, Petkova E, Shah PS. Phosphoinositide 3-kinase inhibitors in advanced breast cancer: A systematic review and meta-analysis. Eur J Cancer 2018; 91: 38-46. DOI: https://doi.org/10.1016/j.ejca.2017.12.010
Rezaianzadeh A, Ghorbani M, Rezaeian S, Kassani A. Red meat consumption and breast cancer risk in premenopausal women: A systematic review and meta-analysis. Middle East J Cancer 2018; 9(1): 5-12.
Rizeq B, Zakaria Z, Ouhtit A. Towards understanding the mechanisms of actions of carcinoembryonic antigen-related cell adhesion molecule 6 in cancer progression. Cancer Sci 2018; 109(1): 33-42. DOI: https://doi.org/10.1111/cas.13437
Rodgers KM, Udesky JO, Rudel RA, Brody JG. Environmental chemicals and breast cancer: An updated review of epidemiological literature informed by biological mechanisms. Environ Res 2018; 160: 152-82. DOI: https://doi.org/10.1016/j.envres.2017.08.045
Shaheed SU, Tait C, Kyriacou K, Linforth R, Salhab M, Sutton C. Evaluation of nipple aspirate fluid as a diagnostic tool for early detection of breast cancer. Clin Proteomics 2018; 15; 3(1) DOI: https://doi.org/10.1186/s12014-017-9179-4
Sofi NY, Jain M, Kapil U, Seenu V, Yadav CP, Pandey RM, et al. Reproductive factors, nutritional status and serum 25(OH)D levels in women with breast cancer: A case control study. J Steroid Biochem Mol Biol 2018; 175: 200-04. DOI: https://doi.org/10.1016/j.jsbmb.2017.11.003
Tajbakhsh A, Hasanzadeh M, Rezaee M, Khedri M, Khazaei M, ShahidSales S, et al. Therapeutic potential of novel formulated forms of curcumin in the treatment of breast cancer by the targeting of cellular and physiological dysregulated pathways. J Cell Physiol 2018; 233(3): 2183-92. DOI: https://doi.org/10.1002/jcp.25961
Tan MP, Silva E. Addressing the paradox of increasing mastectomy rates in an era of de-escalation of therapy: Communication strategies. Breast 2018; 38: 136-43. DOI: https://doi.org/10.1016/j.breast.2017.12.010
Verma V, Simone CB, Mishra MV. Quality of Life and Patient-Reported Outcomes Following Proton Radiation Therapy: A Systematic Review. J Nat Cancer Inst 2018; 110(4):341-53. doi: 10.1093/jnci/djx208 DOI: https://doi.org/10.1093/jnci/djx208
Ye JC, Formenti SC. Integration of radiation and immunotherapy in breast cancer - Treatment implications. Breast 2018; 38: 66-74. DOI: https://doi.org/10.1016/j.breast.2017.12.005
Zaidi S, Hussain S, Verma S, Veqar Z, Khan A, Nazir SU, et al. Efficacy of complementary therapies in the quality of life of breast cancer survivors. Front Oncol 2018; 7(JAN) 7:326. doi: 10.3389/fonc.2017.00326 DOI: https://doi.org/10.3389/fonc.2017.00326
Zhang Y, Lin L, Li H, Hu Y, Tian L. Effects of acupuncture on cancer-related fatigue: a meta-analysis. Supportive Care in Cancer 2018; 26(2): 415-25. DOI: https://doi.org/10.1007/s00520-017-3955-6
Carlomagno N, Incollingo P, Tammaro V, Peluso G, Rupealta N, Chiacchio G, et al. Diagnostic, Predictive, Prognostic, and Therapeutic Molecular Biomarkers in Third Millennium: A Breakthrough in Gastric Cancer. BioMed Res Int 2017(7869802). doi:10.1155/2017/7869802 DOI: https://doi.org/10.1155/2017/7869802
Caviglia GP, Bosco C. Helicobacter pylori, gastric cancer and gastric cancer stem cells. Minerva Biotecnol 2017; 29(4): 180-87. DOI: https://doi.org/10.23736/S1120-4826.17.02354-0
Capurso G, Lahner E. The interaction between smoking, alcohol and the gut microbiome. Best Pract Res Clin Gastroenterol 2017; 31(5): 579-88. DOI: https://doi.org/10.1016/j.bpg.2017.10.006
Strand MS, Lockhart AC, Fields RC. Genetics of Gastric Cancer. Surg Clin North Am 2017; 97(2): 345-70. DOI: https://doi.org/10.1016/j.suc.2016.11.009
Ashktorab H, Kupfer SS, Brim H, Carethers JM. Racial Disparity in Gastrointestinal Cancer Risk. Gastroenterology 2017; 153(4): 910-23. DOI: https://doi.org/10.1053/j.gastro.2017.08.018
Choi SJ, Shin YS, Kang BW, Kim JG, Won KJ, Lieberman PM, et al. DNA hypermethylation induced by Epstein-Barr virus in the development of Epstein-Barr virus-associated gastric carcinoma. Arch Pharmacal Res 2017; 40(8): 894-905. DOI: https://doi.org/10.1007/s12272-017-0939-5
Asghari MH, Moloudizargari M, Ghobadi E, Fallah M, Abdollahi M. Melatonin as a multifunctional anti-cancer molecule: Implications in gastric cancer. Life Sci 2017; 185: 38-45. DOI: https://doi.org/10.1016/j.lfs.2017.07.020
Balakrishnan M, George R, Sharma A, Graham DY. Changing Trends in Stomach Cancer throughout the World. Curr Gastroenterol Rep 2017; 19(36). doi: 10.1007/s11894-017-0575-8 DOI: https://doi.org/10.1007/s11894-017-0575-8
Rokkas T, Rokka A, Portincasa P. A systematic review and meta-analysis of the role of Helicobacter pylori eradication in preventing gastric cancer. Ann Gastroenterol 2017; 30(4): 414-23. DOI: https://doi.org/10.20524/aog.2017.0144
Butcher LD, den Hartog G, Ernst PB, Crowe SE. Oxidative Stress Resulting from Helicobacter pylori Infection Contributes to Gastric Carcinogenesis. Cell Mol Gastroenterol Hepatol 2017; 3(3): 316-22. DOI: https://doi.org/10.1016/j.jcmgh.2017.02.002
Desiderio J, Chao J, Melstrom L, Warner S, Tozzi F, Fong Y, et al The 30-year experience—A meta-analysis of randomised and high-quality non-randomised studies of hyperthermic intraperitoneal chemotherapy in the treatment of gastric cancer. Eur J Cancer 2017; 79: 1-14. DOI: https://doi.org/10.1016/j.ejca.2017.03.030
Ellison LM, Man Y, Stojadinovic A, Xin H, Avital I. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in treatment of gastric cancer with peritoneal carcinomatosis. Chinese J Cancer Res 2017; 29(1): 86-92. DOI: https://doi.org/10.21147/j.issn.1000-9604.2017.01.10
Eom BW, Kim YI, Yoon HM, Cho SJ, Lee JY, Kim CG, et al . Current status and challenges in sentinel node navigation surgery for early gastric cancer. Chin J Cancer Res 2017; 29(2): 93-9. DOI: https://doi.org/10.21147/j.issn.1000-9604.2017.02.01
Flanagan DJ, Vincan E, Phesse TJ. Winding back Wnt signalling: potential therapeutic targets for treating gastric cancers. Br J Pharmacol 2017; 174(24): 4666-83. DOI: https://doi.org/10.1111/bph.13890
Haghi A, Azimi H, Rahimi R. A Comprehensive Review on Pharmacotherapeutics of Three Phytochemicals, Curcumin, Quercetin, and Allicin, in the Treatment of Gastric Cancer. J Gastrointestinal Cancer 2017; 48(4): 314-20. DOI: https://doi.org/10.1007/s12029-017-9997-7
Joo MK, Park JJ, Chun HJ. Additional Benefits of Routine Drugs on Gastrointestinal Cancer: Statins, Metformin, and Proton Pump Inhibitors. Dig Dis 2017; 36(1): 1-14. DOI: https://doi.org/10.1159/000480149
Kayamba V, Heimburger DC, Morgan DR, Atadzhanov M, Kelly P. Exposure to biomass smoke as a risk factor for oesophageal and gastric cancer in low-income populations: A systematic review. Malawi Med J 2017; 29(2): 212-17. DOI: https://doi.org/10.4314/mmj.v29i2.25
Liu H, Song J, Yang Z, Zhang X. Association between TNF-α 238 G/A polymorphism and gastric carcinoma risk: A systematic review and a meta-analysis. Int J Clin Exp Med 2017; 10(8): 11327-36.
Makale MT, Kesari S, Wrasidlo W. The autonomic nervous system and cancer. Biocybern Biomed Eng 2017; 37(3): 443-52. DOI: https://doi.org/10.1016/j.bbe.2017.05.001
McRae MP. Health Benefits of Dietary Whole Grains: An Umbrella Review of Meta-analyses. J Chiropr Med 2017; 16(1): 10-18. DOI: https://doi.org/10.1016/j.jcm.2016.08.008
Obermannová R, Lordick F. Management of Metastatic Gastric Cancer. Hematol Oncol Clin North Am 2017; 31(3): 469-83. DOI: https://doi.org/10.1016/j.hoc.2017.01.006
Ongaro E, Buoro V, Cinausero M, Caccialanza R, Turri A, Fanotto V, et al. Sarcopenia in gastric cancer: when the loss costs too much. Gastric Cancer 2017; 20(4): 563-72. DOI: https://doi.org/10.1007/s10120-017-0722-9
Özer İ, Bostancı EB, Ulaş M, Özoğul Y, Akoğlu M. Changing trends in gastric cancer surgery. Balkan Med J 2017; 34(1): 10-20. DOI: https://doi.org/10.4274/balkanmedj.2015.1461
Petrelli F, Ghidini M, Barni S, Steccanella F, Sgroi G, Passalacqua R, et al. Prognostic Role of Primary Tumor Location in Non-Metastatic Gastric Cancer: A Systematic Review and Meta-Analysis of 50 Studies. Ann Surg Oncol 2017; 24(9): 2655-68. DOI: https://doi.org/10.1245/s10434-017-5832-4
van der Post RS, Carneiro F. Emerging Concepts in Gastric Neoplasia: Heritable Gastric Cancers and Polyposis Disorders. Surg Pathol Clin 2017; 10(4): 931-45. DOI: https://doi.org/10.1016/j.path.2017.07.011
Wang T, Cai H, Zheng W, Michel A, Pawlita M, Milne G, et al. A Prospective Study of Urinary Prostaglandin E2 Metabolite, Helicobacter pylori Antibodies, and Gastric Cancer Risk. Clin Infect Dis 2017; 64(10): 1380-86. DOI: https://doi.org/10.1093/cid/cix106
Yan Y, Fu G, Ye Y, Ming L. Exosomes participate in the carcinogenesis and the malignant behavior of gastric cancer. Scand J Gastroenterol 2017; 52(5): 499-504. DOI: https://doi.org/10.1080/00365521.2016.1278458
Zavros Y. Initiation and Maintenance of Gastric Cancer: A Focus on CD44 Variant Isoforms and Cancer Stem Cells. Cell Mol Gastroenterol Hepatol 2017; 4(1): 55-63. DOI: https://doi.org/10.1016/j.jcmgh.2017.03.003
Apurva A, Tandon SP, Shetmahajan M, Jiwnani SS, Karimundackal G, Pramesh CS. Surgery for lung cancer—the Indian scenario. Ind J Thorac Cardiovasc Surg 2018; 34: 47-53. DOI: https://doi.org/10.1007/s12055-017-0634-7
Australian Institute of H. and Welfare. Cancer in Australia: Actual incidence data from 1982 to 2013 and mortality data from 1982 to 2014 with projections to 2017. Asia-Pac J Clin Oncol 2018; 14(1): 5-15. DOI: https://doi.org/10.1111/ajco.12761
D'Andrea M, Strolin S, Ungania S, Cacciatore A, Bruzzaniti V, Marconi R, et al. Radiobiological optimization in lung stereotactic body radiation therapy: Are we ready to apply radiobiological models? Front Oncol 2018; 7(321). doi: 10.3389/fonc.2017.00321 DOI: https://doi.org/10.3389/fonc.2017.00321
Elshafay A, Tinh NX, Salman S, Shaheen YS, Othman EB, Elhady MT, et al. Ginsenoside Rk1 bioactivity: A systematic review. Peer J 2017; 5(e3993). doi: 10.7717/peerj.3993 DOI: https://doi.org/10.7717/peerj.3993
Galli G, Corrao G, Imbimbo M, Proto C, Signorelli D, Ganzinelli M, et al. Uncommon mutations in epidermal growth factor receptor and response to first and second generation tyrosine kinase inhibitors: A case series and literature review. Lung Cancer 2018; 115: 135-42. DOI: https://doi.org/10.1016/j.lungcan.2017.12.002
Low M, Ben-Or S. Thoracic Surgery in Early-Stage Small Cell Lung Cancer. Thorac Surg Clin 2018; 28(1): 9-14. DOI: https://doi.org/10.1016/j.thorsurg.2017.08.003
Kerr EM, Martins CP. Metabolic rewiring in mutant Kras lung cancer. FEBS J 2018; 285 (1): 28-41. DOI: https://doi.org/10.1111/febs.14125
New M, Keith R. Early Detection and Chemoprevention of Lung Cancer. 2018, 7(F1000 Faculty Rev):61 doi: 10.12688/f1000research.12433.1 DOI: https://doi.org/10.12688/f1000research.12433.1
MacManus M, Everitt S. Treatment Planning for Radiation Therapy. PET Clin 2018; 13(1): 43-57. DOI: https://doi.org/10.1016/j.cpet.2017.08.005
Mehta A, Barreto G. Non-invasive approaches for lung cancer diagnosis. Ind J Thorac Cardiovasc Surg 2018; 34: 11-19. DOI: https://doi.org/10.1007/s12055-017-0600-4
Nathenson MJ, Conley AP, Sausville E. Immunotherapy: A New (and Old) Approach to Treatment of Soft Tissue and Bone Sarcomas. Oncol 2018; 23(1): 71-83. DOI: https://doi.org/10.1634/theoncologist.2016-0025
Niyonkuru A, Bakari KH, Lan X. 18F-Fluoro-2-Deoxy-D-Glucose PET/Computed Tomography Evaluation of Lung Cancer in Populations with High Prevalence of Tuberculosis and Other Granulomatous Disease. PET Clin 2018; 13(1): 19-31. DOI: https://doi.org/10.1016/j.cpet.2017.08.003
Oronsky B, Ma P, Reid TR, Cabrales P, Lybeck M, Oronsky A, et al. Navigating the “No Man's Land” of TKI-Failed EGFR-Mutated Non–Small Cell Lung Cancer (NSCLC): A Review. Neoplasia 2018; 20(1): 92-8. DOI: https://doi.org/10.1016/j.neo.2017.11.001
Rogers LK, Cismowski MJ. Oxidative stress in the lung – The essential paradox. Curr Opin Toxicol 2018; 7: 37-43. DOI: https://doi.org/10.1016/j.cotox.2017.09.001
Vangimalla SS, Ganesan M, Kharbanda KK, Osna NA. Bifunctional enzyme JMJD6 contributes to multiple disease pathogenesis: New twist on the old story. Biomole 2017; (7): 41. doi: 10.3390/biom7020041 DOI: https://doi.org/10.3390/biom7020041
Sharma A, Viswanath B, Park YS. Role of probiotics in the management of lung cancer and related diseases: An update. J Funct Foods 2018; 40:625-33. DOI: https://doi.org/10.1016/j.jff.2017.11.050
Ali J, Sabiha B, Jan HU, Haider SA, Khan AA, Ali SS. Genetic etiology of oral cancer. Oral Oncol 2017; 70: 23-8. DOI: https://doi.org/10.1016/j.oraloncology.2017.05.004
Benly DP. Management of squamous cell carcinoma of tongue – A review. J Pharm Sci Res 2017; 9(4): 453-55. Available from http://www.jpsr.pharmainfo.in/Documents/ Volumes/vol9Issue04/jpsr09041720.pdf
Adami GR, Tang JL, Markiewicz MR. Improving accuracy of RNA-based diagnosis and prognosis of oral cancer by using noninvasive methods. Oral Oncol 2017; 69: 62-7. DOI: https://doi.org/10.1016/j.oraloncology.2017.04.001
Bandeira CM, de Almeida AÁ, Carta CFL, Almeida JD, Kaminagakura E. How to improve the early diagnosis of oral cancer? Braz Dent Sci 2017; 20(4): 25-31. DOI: https://doi.org/10.14295/bds.2017.v20i4.1439
Chaitanya NC, Muthukrishnan A, Babu DBG, Kumari CS, Lakshmi MA, Palat G. et al. Role of vitamin e and vitamin a in oral mucositis induced by cancer chemo/radiotherapy- a meta-analysis. J Clin Diagn Res 2017; 11(5): ZE06-ZE09. doi: 10.7860/JCDR/2017/26845.9905 DOI: https://doi.org/10.7860/JCDR/2017/26845.9905
Chau L, Jabara JT, Lai W, Svider PF, Warner BM, Lin HS, et al. Topical agents for oral cancer chemoprevention: A systematic review of the literature. Oral Oncol 2017; 67: 153-59. doi: 10.1016/j.oraloncology.2017.02.014 DOI: https://doi.org/10.1016/j.oraloncology.2017.02.014
Figueira JA, Veltrini VC. Photodynamic therapy in oral potentially malignant disorders—Critical literature review of existing protocols. Photodiagn Photodyn Ther 2017; 20: 125-29. DOI: https://doi.org/10.1016/j.pdpdt.2017.09.007
Ferguson BL, Barber S, Asher IH, Wood CR. Role of Oral Microbial Infections in Oral Cancer. Dent Clin North Am 2017; 61(2): 425-34. DOI: https://doi.org/10.1016/j.cden.2016.12.009
Hadziabdic N, Sulejmanagic H, Kurtovic-Kozaric A. The role of general dental practitioners in the detection of early-stage oral malignancies–A review. J Oral Maxillofacial Surg Med Pathol 2017; 29(4): 363-76. DOI: https://doi.org/10.1016/j.ajoms.2017.03.009
Klein Nulent TJW, Noorlag R, Van Cann EM, Pameijer FA, Willems SM, Yesuratnam A, et al. Intraoral ultrasonography to measure tumor thickness of oral cancer: A systematic review and meta-analysis. Oral Oncol 2018; 77: 29-36. DOI: https://doi.org/10.1016/j.oraloncology.2017.12.007
Kujan O, Shearston K, Farah CS. The role of hypoxia in oral cancer and potentially malignant disorders: a review. J Oral Pathol Med 2017; 46(4): 246-52. DOI: https://doi.org/10.1111/jop.12488
Miranda J, Monteiro L, Albuquerque R, Pacheco JJ, Khan Z, Lopez-Lopez J, et al . Coffee is protective against oral and pharyngeal cancer: A systematic review and meta-analysis. Med Oral Patol Oral Cir Bucal 2017; 22(5): e554-e61. doi:10.4317/medoral.21829 DOI: https://doi.org/10.4317/medoral.21829
Singhal K, Raj N, Gupta K, Singh S. Probable benefits of green tea with genetic implications. J Oral Maxillofac Pathol 2017; 21(1): 107-14. DOI: https://doi.org/10.4103/0973-029X.203758
Villa A, Akintoye SO. Dental Management of Patients Who Have Undergone Oral Cancer Therapy. Dental Clinic North Am 2018; 62(1): 131-42. DOI: https://doi.org/10.1016/j.cden.2017.08.010
Wang TH, Hsia SM, Shih YH, Shieh TM. Association of smoking, alcohol use, and betel quid chewing with epigenetic aberrations in cancers. Int J Mol Sci 2017; 18(1210). doi: 10.3390/ijms1806121 DOI: https://doi.org/10.3390/ijms18061210
Salem AA, Mackenzie GG. Pancreatic cancer: A critical review of dietary risk. Nutr Res 2018; 52: 1-13. DOI: https://doi.org/10.1016/j.nutres.2017.12.001
Smigiel JM, Parameswaran N, Jackson MW. Targeting pancreatic cancer cell plasticity: The latest in therapeutics. Cancers 2018; 10(1):14. doi: 10.3390/cancers10010014 DOI: https://doi.org/10.3390/cancers10010014
Yamaguchi J, Yokoyama Y, Kokuryo T, Ebata T, Nagino M. Cells of origin of pancreatic neoplasms. Surg Today 2018; 48(1): 9-17. DOI: https://doi.org/10.1007/s00595-017-1501-2
Marrocchio C, Dababou S, Catalano C, Napoli A. Nonoperative Ablation of Pancreatic Neoplasms. Surg Clin J North Am 2018; 98(1): 127-40. DOI: https://doi.org/10.1016/j.suc.2017.09.010
Martinez-Bosch N, Vinaixa J, Navarro P. Immune evasion in pancreatic cancer: From mechanisms to therapy. Cancers 2018; 106. doi: 10(1):6 3390/cancers10010006 DOI: https://doi.org/10.3390/cancers10010006
Torphy RJ, Schulick RD. Screening of Patients at Risk for Familial Pancreatic Cancer: What Is Beneficial? Surg Clin North Am 2018; 98(1): 25-35. DOI: https://doi.org/10.1016/j.suc.2017.09.003
Vreeland TJ, Katz MHG. Timing of Pancreatic Resection and Patient Outcomes: Is There a Difference? Surg Clin North Am 2018; 98(1): 57-71. DOI: https://doi.org/10.1016/j.suc.2017.09.006
Aziz SW, Aziz MH. Protective molecular mechanisms of resveratrol in UVR-induced Skin carcinogenesis. Photodermatol Photoimmunol Photomed 2018; 34(1): 35-41. DOI: https://doi.org/10.1111/phpp.12336
Bagde A, Mondal A, Singh M. Drug delivery strategies for chemoprevention of UVB-induced skin cancer: A review. Photodermatol Photoimmunol Photomed 2018; 34(1): 60-8. DOI: https://doi.org/10.1111/phpp.12368
Dai NT, Chang HI, Wang YW, Fu KY, Huang TC, Huang NC, et al. Restoration of skin pigmentation after deep partial or full-thickness burn injury. Adv Drug Deliv Rev 2018; 123: 155-64. DOI: https://doi.org/10.1016/j.addr.2017.10.010
Didona D, Paolino G, Bottoni U, Cantisani C. Non melanoma skin cancer pathogenesis overview. Biomed 2018; 6(1):6. doi: 10.3390/biomedicines6010006 DOI: https://doi.org/10.3390/biomedicines6010006
Salih AM, Kakamad FH, Baba HO, Salih RQ, Hawbash MR, Mohammed SH, et al. Porocarcinoma; presentation and management, a meta-analysis of 453 cases. Ann Med Surg 2017; 20: 74-9. DOI: https://doi.org/10.1016/j.amsu.2017.06.027
Gandini S, Palli D, Spadola G, Bendinelli B, Cocorocchio E, Stanganelli I, et al. Anti-hypertensive drugs and skin cancer risk: a review of the literature and meta-analysis. Cri Rev Oncol/Hematol 2018; 122: 1-9. DOI: https://doi.org/10.1016/j.critrevonc.2017.12.003
Gies P, Van Deventer E, Green AC, Sinclair C, Tinker R. Review of the Global Solar UV Index 2015 Workshop Report. Health Phys 2018; 114(1): 84-90. DOI: https://doi.org/10.1097/HP.0000000000000742
Minocha R, Damian DL, Halliday GM. Melanoma and nonmelanoma skin cancer chemoprevention: A role for nicotinamide? Photodermatol Photoimmunol Photomed 2018; 34(1): 5-12. DOI: https://doi.org/10.1111/phpp.12328
Penta D, Somashekar BS, Meeran SM. Epigenetics of skin cancer: Interventions by selected bioactive phytochemicals. Photodermatol Photoimmunol Photomed 2018; 34(1): 42-9. DOI: https://doi.org/10.1111/phpp.12353
Sample A, He YY. Mechanisms and prevention of UV-induced melanoma. Photodermatol Photoimmunol Photomed 2018; 34(1): 13-24. DOI: https://doi.org/10.1111/phpp.12329
Yuan X, Zhu C, Wang M, Mo F, Du W, Ma X. Night shift work increases the risks of multiple primary cancers in women: A systematic review and meta-analysis of 61 articles. 2018; 27(1): 25-40. Cancer Epidemiol Biomark Prev 2018; 27(1): 25-40. DOI: https://doi.org/10.1158/1055-9965.EPI-17-0221
Sharma P, Montes de Oca MK, Alkeswani AR, McClees SF, Das T, et al. Tea polyphenols for the prevention of UVB-induced skin cancer. Photodermatol Photoimmunol Photomed 2018; 34(1): 50-9. DOI: https://doi.org/10.1111/phpp.12356
Sherwani MA, Tufail S, Muzaffar AF, Yusuf N. The skin microbiome and immune system: Potential target for chemoprevention? Photodermatol Photoimmunol Photomed 2018; 34(1): 25-34. DOI: https://doi.org/10.1111/phpp.12334
Xiao F, Pu J, Wen Q, Huang Q, Zhang Q, Huang B, et al. Association between the ERCC2 Asp312Asn polymorphism and risk of cancer. Oncotarget 2017; 8(29): 48488-506. DOI: https://doi.org/10.18632/oncotarget.17290
Shokoohinia Y, Jafari F, Mohammadi Z, Bazvandi L, Hosseinzadeh L, Chow N, et al. Potential anticancer properties of osthol: A comprehensive mechanistic review. Nutr. 2018; 10(36). DOI: https://doi.org/10.3390/nu10010036
Yuza K, Nagahashi M, Watanabe S, Takabe K, Wakai T. Hypermutation and microsatellite instability in gastrointestinal cancers. Oncotarget 2017; 8(67): 112103-15. DOI: https://doi.org/10.18632/oncotarget.22783
Zirtiloglu A, Cil I, Mehmet VF, Tural D. What are the optimal treatment modalities according to age group in gastric cancer patients? J B U O N 2017; 22(2): 312-19.
Jemal A, Ward EM, Johnson CJ, Cronin KA, Ma J, Ryerson AB, et al. Annual Report to the Nation on the Status of Cancer, 1975-2014, Featuring Survival. J Nat Cancer Inst 2017; 109(9). doi: 10.1093/jnci/djx030 DOI: https://doi.org/10.1093/jnci/djx030
Lin AB, McNeely SC, Beckmann RP. Achieving precision death with cell-cycle inhibitors that target DNA replication and repair. Clin Cancer Res 2017; 23(13): 3232-40. DOI: https://doi.org/10.1158/1078-0432.CCR-16-0083
Torquato HFV, Goettert MI, Justo GZ, Paredes-Gamero EJ. Anti-cancer phytometabolites targeting cancer stem cells. Curr Genom 2017; 18(2): 156-74. DOI: https://doi.org/10.2174/1389202917666160803162309
Cooperman AM, Iskandar ME, Wayne MG, Steele JG. Prevention and Early Detection of Pancreatic Cancer. Surg Clin North Am 2018; 98(1): 1-12. DOI: https://doi.org/10.1016/j.suc.2017.09.001
Tsoi KKF, Hirai HW, Chan FCH, Griffiths S, Sung JJY. Cancer burden with ageing population in urban regions in China: Projection on cancer registry data from World Health Organization. Br Med Bull 2017; 121(1): 83-94. DOI: https://doi.org/10.1093/bmb/ldw050
Veillon L, Fakih C, Abou-El-Hassan H, Kobeissy F, Mechref Y. Glycosylation Changes in Brain Cancer. ACS Chem Neurosci 2018; 9(1): 51-72. DOI: https://doi.org/10.1021/acschemneuro.7b00271
Zulfiqar B, Mahroo A, Nasir K, Farooq RK, Jalal N, Rashid MU, et al. Nanomedicine and cancer immunotherapy: Focus on indoleamine 2,3-dioxygenase inhibitors. Onco Targets Ther 2017; 10: 463-76. DOI: https://doi.org/10.2147/OTT.S119362
Gresham G, Schrack J, Gresham LM, Shinde AM, Hendifar AE, Tuli R, et al. Wearable activity monitors in oncology trials: Current use of an emerging technology. Contemp Clin Trials 2018; 64: 13-21. DOI: https://doi.org/10.1016/j.cct.2017.11.002
Lotha R, Sivasubramanian A. Flavonoids nutraceuticals in prevention and treatment of cancer: A review. Asian J Pharm Clin Res 2018; 11(1): 42-7. DOI: https://doi.org/10.22159/ajpcr.2018.v11i1.23410
Moradzadeh M, Sadeghnia HR, Tabarraei A, Sahebkar A. Anti-tumor effects of crocetin and related molecular targets. J Cell Physiol 2018; 233 (3): 2170-82. DOI: https://doi.org/10.1002/jcp.25953
Pires BRB, Silva RCMC, Ferreira GM, Abdelhay E. NF-kappaB: Two sides of the same coin. Genes 2018; 9(24). doi: 10.3390/genes9010024 DOI: https://doi.org/10.3390/genes9010024
Downloads
Published
How to Cite
Issue
Section
